
Before the network of more than 100 locations, there was a Seattle lab, a report on a desk, and a research technician learning how evidence can stop a crisis before it spreads.

A Seattle microbiologist built a career around a stubborn proposition: food should be treated as risky before a crisis proves it was. His instruments are DNA, probability and the willingness to look for trouble.

Before PathogenDx, Milan Patel built cars, ran an electronics company, learned finance at Intel and watched his first startup fail. His third venture turns tiny patterns on glass into same-shift answers for laboratories - a career assembled from engineering, money and the nerve to ship.
PathogenDx spent years turning a three-dimensional DNA microarray into a commercial test. Cannabis labs supplied the opening; poultry processors may supply the scale.